1. Home
  2. COCP vs SNAL Comparison

COCP vs SNAL Comparison

Compare COCP & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

BUY

Current Price

$1.11

Market Cap

21.6M

Sector

Health Care

ML Signal

BUY

Logo Snail Inc.

SNAL

Snail Inc.

BUY

Current Price

$2.27

Market Cap

21.2M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
COCP
SNAL
Founded
N/A
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
21.2M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
COCP
SNAL
Price
$1.11
$2.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 51.5K
20.0K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
★ 120.00
EPS
★ N/A
N/A
Revenue
$12,712,091.00
★ $81,225,622.00
Revenue This Year
N/A
$22.50
Revenue Next Year
N/A
$9.55
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.76
$0.34
52 Week High
$2.03
$5.92

Technical Indicators

Market Signals
Indicator
COCP
SNAL
Relative Strength Index (RSI) 39.79 28.95
Support Level $0.99 $0.44
Resistance Level $1.12 $2.70
Average True Range (ATR) 0.07 0.13
MACD -0.02 0.00
Stochastic Oscillator 4.55 21.82

Price Performance

Historical Comparison
COCP
SNAL

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

Share on Social Networks: